Malignancies Flashcards

(147 cards)

1
Q

RAS activates this pathway

A

PI3K pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

This pathway leads to progrowth metabolism (Warburg)

A

PI3K pathway
Activated by Ras

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RAS activates this transcription factor which stimulates production of MYC and cyclins

A

BRAF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

BRAF is activated by RAS and induces production of these 2

A

MYC and cyclins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BRAF is activated by Ras and induces production of this, which leads to pro-growth pathways

A

MYC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

This is dysregulated in neuroblastoma

A

MYC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Proteins that cause progression through the cell cycle

A

Cyclins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cyclins attach to and activate these

A

Cyclin dependent kinases (CDKs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

These attach to and activate cyclin dependent kinases (CDKs)

A

cyclins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

These phosphorylate various proteins to produce growth, division, metabolic effects
Lose activity when the attached cyclin degrades

A

Cyclin dependent kinases (CDKs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Two checkpoints in the cell cycle

A

Between G1-S progression and G2-M progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

This cyclin binds CDK4

A

Cyclin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cyclin D binds this CDK

A

CDK4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MYC stimulates this cyclin pathway

A

Cyclin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

This stimulates the cyclin D pathway

A

MYC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

This is inactivated and allows S phase entry

A

Rb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tumor suppressor gene that is lost in Familial Retinoblastoma

A

Rb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Translocation in mantle cell lymphoma

A

t(11:14) of cyclin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ras may be dysregulated by this type of mutation

A

Gain of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

This inhibits many proto-oncogenes

A

p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Tumor suppressor gene that inhibits cyclin dependent kinase (CDK4-Cyclin D complex)
Often lost in melanoma

A

p16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

p16 inhibits this

A

Cyclin dependent kinase (CDK4-cyclin D complex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Tumor suppressor gene that is often lost in melanoma

A

p16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PTEN inhibits this

A

PI3K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
This inhibits PI3K
PTEN
26
This inhibits E2F transcription factor
Rb
27
Rb inhibits this transcription factor
E2F
28
Is RAS active or inactive when phosphorylated?
Active
29
To prevent inappropriate growth, these immediately dephosphorylate the RAS-GTP to its inactive form
GAP proteins Are tumor suppressor proteins
30
GTPase activating protein (tumor suppressor gene) that normally inactivates RAS:GTP --> GDP, and when lost causes neurofibromatosis 1
NF1
31
Tumor suppressor gene that inhibits PI3K/AKt signaling
PTEN (phosphatase and tensin homologue)
32
Autosomal dominant disorder involving loss of function mutation of NF1 (GAP)
Neurofibromatosis 1
33
Neurofibromatosis 1 is caused by this
Loss of function mutation of NF1 gene
34
Autosomal dominant disorder caused by a loss of function mutation in PTEN gene
Cowden syndrome
35
Cowden syndrome is caused by this
Loss of function mutation of PTEN gene
36
Endometrial carcinoma, breast carcinoma, thyroid cancer, hamartomatous intestinal polyps and hamartomatous skin lesions are features of this condition
Cowden syndrome
37
Active form of Rb tumor suppressor gene is this
Hypophosphorylated
38
This binds and inactivates E2F, a pro-growth transcription factor
Rb
39
Rb binds and inactivates this
E2F, a pro-growth transcription factor
40
E2F is this
Pro-growth transcription factor
41
Autosomal dominant condition involving the inheritance of one allele, so only one more cell needs a mutation to produce a tumor
Familial Retinoblastoma
42
Inherited loss of a p53 copy (one hit) 25x risk of malignancy by age 50 Sarcomas, adrenal carcinoma, breast cancer, leukemia
Li-Fraumeni Syndrome
43
Li-Fraumeni Syndrome is an inherited loss of this
A p53 copy
44
Sarcomas and adrenal carcinoma are characteristic of this condition caused by loss of p53 copy
Li-Fraumeni Syndrome
45
Tumor suppressor gene lost in colon cancer
APC Part of WNT signaling pathway to stabilize beta-catenin, a co-transcription factor
46
Part of WNT signaling pathway to stabilize beta-catenin, a co-transcription factor Lost in colon cancer
APC
47
APC is a tumor suppressor gene lost in this
Colon cancer
48
Tumor suppressor gene lost in signet ring cancer of breast and stomach
CDH1
49
Tumor suppressor gene that encodes E-cadherin adhesion molecule
CDH1
50
Tumor suppressor gene lost in renal cell carcinomas
VHL
51
Gain of function of these lead to neoplasia
Oncogenes
52
Loss of function mutations of these lead to neoplasia
Tumor suppressor genes
53
Often a single mutation of these is needed for neoplasia (dominant pattern of inheritance)
Oncogenes
54
Usually need loss of both genes of these for neoplasia (recessive pattern of inheritance)
Tumor suppressor genes
55
Growth promoting metabolic alterations Cells enter preferential fermentative metabolism Provides excess carbon macromolecules at expense of energy
Warburg effect
56
p53 is this type of apoptotic force
Pro-apoptotic
57
bcl-2 is this type of apoptotic force
Anti-apoptotic
58
This is over-expressed in follicular lymphoma t(14;18)
bcl-2
59
Over-expression of this results in slow-growing, indolent tumors Incurable because low proliferation
bcl-2
60
Proteins that form channels in mitochondrial membrane
Bax/Bak
61
Protein that binds bax/bak and prevents its dimerization Results in no mitochondrial permeability
Bcl-2
62
This protein activates bax/bak and relocates to mitochondrion Results in increased mitochondrial permeability and caspase activation
p53
63
Cellular immortality most often involves this mechanism
Telomere
64
Some cancers reactivate telomerase function, and this is one mechanism
loss of p53
65
Some cancers have intrinsic telomerase activity by this method
Retain stem cell population
66
New vascular supply is needed for tumors to grow beyond this
1-2 mm
67
This type of tumor environment promotes HIF-enabled transcription
Ischemic
68
This inhibits VEGF Loss allows VEGF to promote vessel growth (tumor angiogenesis)
p53
69
Monoclonal antibody that inhibits VEGF
Bevacizumab
70
Bevacizumab inhibits this
VEGF Prevents angiogenesis
71
Transcription factor activated in ischemic tumor environment that promotes transcription of VEGF
Hypoxia inducible factor (HIF)
72
Cell adhesion molecule that is often lost or suppressed to allow metastatic epithelial cells to detach from each other
E-cadherin
73
In normal cells, epithelial integrins bind this on the matrix
Laminin
74
In normal cells, these bind matrix laminin
Epithelial integrins
75
In cancer, this is lost, which usually binds matrix laminin Allows cells to attach to remodeled matrix
Integrin
76
In cancer, matrix is induced to produce this Allows cells to attach to remodeled matrix
Fibronectin
77
Morphological stromal reaction to invasion
Desmoplasia
78
In order to survive intravascular travel, metastatic cells use this coating for stability and evasion of surveillance
Platelet
79
2 complementary adhesion molecules that allow metastatic cancer cell implantation in bone
E-cadherin and osteoblast N-cadherin
80
Antigens on tumor cells which are not recognized as self-antigens
Neoantigens
81
Tumor cells upregulate this which inhibits APCs
CTLA-4
82
Tumor cells upregulate CTLA-4, which inhibits this
APCs
83
2 proteins that tumor cells upregulate in order to inhibit/avoid T cell killing
CTLA-4 (inhibits APCs) PD-L1 and PD-L2
84
Anti-CTLA-4 antibody
Ipilimumab
85
Ipilimumab is a monoclonal antibody against this
CTLA-4
86
Pembrolizumab and Nivolumab are antibodies against this
PD-1
87
Atezolizumab, Avelumab and Durvalumab are antibodies against this
PD-L1
88
Most frequently mutated gene in human cancer
p53
89
Normally p53 is inactivated by this
MDM2 ubiquitination
90
Protein that is normally inactivated by MDM2 ubiquitination
p53
91
Stressed cells have decrease MDM2 binding, which increases activity of this
p53
92
Stressed cells have decreased binding of this, which results in increased p53 activity
MDM2
93
This maintains Rb in active hypophosphorylated form
p21
94
p21 maintains this in active hypophosphorylated form
Rb
95
p53 increases activity of this CDK-inhibitor which maintains Rb in active hypophosphorylated form
p21
96
p53 can increase transcription of this to increase mitochondrial permeability and induce apoptosis
BAX
97
Tandem nucleotide repeats, normally of uniform constant length Hallmark of loss of mismatch repair enzymes
Microsatellite instability (MSI)
98
Microsatellite instability (MSI) is hallmark of this
Loss of mismatch repair enzymes
99
Syndrome of defective MMR enzymes
Lynch syndrome
100
System to excise and correct pyrimidine residues cross-linked by UV radiation
Nucleotide excision repair
101
Disorder of NER enzyme loss of function (defect in components of excision repair) HIGH rates of UV induced skin cancers (Squamous cell and Basal cell)
Xeroderma Pigmentosa
102
Repair of double stranded DNA breaks and DNA cross-links
Homologous recombination
103
Condition caused by Mutations/defects in Homologous recombination factors Aplastic anemia, leukemia
Fanconi anemia
104
Cells that normally break and rejoin DNA, and errors in this produce frequent translocations
Lymphoid cells
105
Translocation in Burkitt Lymphoma
t(8:14)
106
Translocation of t(8:14) is characteristic of this
Burkitt Lymphoma
107
Translocation of t(14:18) is characteristic of this
Follicular lymphoma
108
Translocation of t(11:14) is characteristic of this
Mantle cell lymphoma
109
Translocation in Follicular Lymphoma
t(14:18)
110
Translocation in Mantle Cell Lymphoma
t(11:14)
111
Chemical carcinogen that preferentially causes specific mutation in TP53 codon 249
Aspergillus aflatoxin
112
Aspergillus aflatoxin results in this condition
Hepatocellular carcinoma
113
Hepatocellular Carcinoma can be caused by this chemical carcinogen
Aspergillus Aflatoxin
114
Aflatoxin preferentially causes this specific mutation
TP53 codon 249 (G:C --> T:A)
115
Type of specific UV radiation that produces pyrimidine dimers, especially T-T pairing
UV-B (280-320 nm)
116
Acute myeloid leukemia and Thyroid malignancies can be produced from this
Ionizing radiation
117
Infection that infects B cells via CD21 (complement receptor)
EBV
118
EBV infects these cells
B cells
119
EBV infects B cells via this
CD21, complement receptor
120
Infection that binding produces viral encoded proteins, LMP-1 and EBNA-2
EBV
121
Viral encoded proteins produced from EBV infecting B cells via CD21
LMP-1 and EBNA-2
122
Viral encoded protein with stimulated CD40 activated form that mimics helper T cell signaling, leading to B cell proliferation; also activates bcl2 and prevents apoptosis
LMP-1
123
The viral encoded protein LMP-1 results in these 2 main actions
B cell proliferation Prevents apoptosis
124
Viral encoded protein EBNA2 activates this
Cyclin D1 (leads to proliferation)
125
Viral encoded protein that activates Cyclin D1, leads to proliferation
EBNA2
126
EBV results in polyclonal B cell proliferation, and this condition
Infectious Mononucleosis
127
What most commonly causes infectious mononucleosis?
EBV infection
128
Infectious mononucleosis involves proliferation of these cells as a result of EBV infection
Polyclonal B cell proliferation
129
EBV infection in patient with deficient immune system increases likelihood of this
t(8:14) = Burkitt lymphoma
130
This type of infection in patient with deficient immune system increases likelihood of t(8:14), leading to Burkitt Lymphoma
EBV
131
Microbial infection that can cause adult T cell leukemia/lymphoma
HTLV1
132
Microbial infection that can cause mucosal squamous cell carcinomas
HPV 16/18
133
Microbial infection that can cause gastric carcinoma and gastric MALT lymphoma
H. pylori
134
Microbial infection that can cause hepatocellular carcinoma
Hep C and B
135
Microbial infection that can cause nasopharyngeal carcinoma
EBV
136
Microbial infection that can cause B cell lymphomas in immune suppressed patients
EBV
137
These tumors often are functional
Endocrine
138
Parathyroid adenoma secretes these hormones
Prolactin, ACTH
139
Adrenal tumor secretes these hormones
Catecholamines (epinephrine)
140
Pancreatic tumor secretes this
Insulin
141
Signs and symptoms due to tumor but not explained by mass or function of tissue of origin
Paraneoplastic syndromes
142
Hypercatabolic state not explain by low caloric intake Fat and muscle loss Most often with advanced cancers Thought to be due to TNF; other inflammatory mediators
Cancer Cachexia
143
A category used to predict behavior based on the tumor morphology Sometimes uses Degree of Differentiation
Tumor grade
144
An assessment of the extent of tumor spread
Tumor stage
145
What is tumor grade?
Category used to predict behavior based on the tumor morphology
146
What is tumor stage?
Assessment of the extent of tumor spread (describes what the tumor has already done)
147
3 components of tumor stage
T = primary tumor spread (tumor size, invasion of specific structures, vascular invasion) N = are lymph nodes involved M = metastases beyond lymph nodes